Patents by Inventor Guibin CHEN

Guibin CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11262856
    Abstract: An interaction method, device and equipment for operable object. The mobile terminal acquires a moving direction and a moving displacement when moving (S101); an initial position of an operable object is an original position of the operable object before the mobile terminal moves; the mobile terminal determines, according to the moving direction, the moving displacement, and the initial positions of the operable objects, determines an application to be launched corresponding to a screen of the mobile terminal; the application to be launched is displayed on the screen of the mobile terminal (S102); and the application to be launched is launched (S103).
    Type: Grant
    Filed: May 9, 2019
    Date of Patent: March 1, 2022
    Assignee: Beijing Bytedance Network Technology Co., Ltd.
    Inventors: Guibin Chen, Chi Fang, Wei Lu, Huayun Miao, Yonghao Luo, Yi Li, Yumeng Li
  • Publication number: 20210348123
    Abstract: Described herein are cells, cell culture methods, and cell culture media compositions useful for producing and maintaining iPSC-derided cell lines that are of higher purity and maintain cell type integrity better than current iPSC-derived cell lines. Also disclosed are methods of using the described cells and media, such as therapeutic methods of use for the described cells. The described cells include iPSC-derived mesodermal precursor cells (MPC), which itself may differentiate into at least four different cell types. When cultured under appropriate conditions, the mesodermal precursor cells can be used to produce hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), smooth muscle cells (SMC), or unlimited functional endothelial cells (UFEC). One characteristic that makes the described cells desirable is that they can be maintained in culture for a number of days, or passages, without changing phenotype through differentiation.
    Type: Application
    Filed: June 3, 2021
    Publication date: November 11, 2021
    Inventors: Manfred Boehm, Guibin Chen, Mahendra Rao, Andre Larochelle
  • Patent number: 11072778
    Abstract: Described herein are cells, cell culture methods, and cell culture media compositions useful for producing and maintaining iPSC-derived cell lines that are of higher purity and maintain cell type integrity better than current iPSC-derived cell lines. Also disclosed are methods of using the described cells and media, such as therapeutic methods of use for the described cells. The described cells include iPSC-derived mesodermal precursor cells (MPC), which itself may differentiate into at least four different cell types. When cultured under appropriate conditions, the mesodermal precursor cells can be used to produce hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), smooth muscle cells (SMC), or unlimited functional endothelial cells (UFEC). One characteristic that makes the described cells desirable is that they can be maintained in culture for a number of days, or passages, without changing phenotype through differentiation.
    Type: Grant
    Filed: August 19, 2019
    Date of Patent: July 27, 2021
    Assignee: THE USA, AS REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES
    Inventors: Manfred Boehm, Guibin Chen, Mahendra Rao, Andre Larochelle
  • Publication number: 20210055804
    Abstract: An interaction method, device and equipment for operable object.
    Type: Application
    Filed: May 9, 2019
    Publication date: February 25, 2021
    Inventors: Guibin CHEN, Chi FANG, Wei LU, Huayun MIAO, Yonghao LUO, Yi LI, Yumeng LI
  • Publication number: 20200095544
    Abstract: Described herein are cells, cell culture methods, and cell culture media compositions useful for producing and maintaining iPSC-derived cell lines that are of higher purity and maintain cell type integrity better than current iPSC-derived cell lines. Also disclosed are methods of using the described cells and media, such as therapeutic methods of use for the described cells. The described cells include iPSC-derived mesodermal precursor cells (MPC), which itself may differentiate into at least four different cell types. When cultured under appropriate conditions, the mesodermal precursor cells can be used to produce hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), smooth muscle cells (SMC), or unlimited functional endothelial cells (UFEC). One characteristic that makes the described cells desirable is that they can be maintained in culture for a number of days, or passages, without changing phenotype through differentiation.
    Type: Application
    Filed: August 19, 2019
    Publication date: March 26, 2020
    Inventors: Manfred Boehm, Guibin Chen, Mahendra Rao, Andre Larochelle
  • Patent number: 10385313
    Abstract: Described herein are cells, cell culture methods, and cell culture media compositions useful for producing and maintaining iPSC-derived cell lines that are of higher purity and maintain cell type integrity better than current iPSC-derived cell lines. Also disclosed are methods of using the described cells and media, such as therapeutic methods of use for the described cells. The described cells include iPSC-derived mesodermal precursor cells (MPC), which itself may differentiate into at least four different cell types. When cultured under appropriate conditions, the mesodermal precursor cells can be used to produce hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), smooth muscle cells (SMC), or unlimited functional endothelial cells (UFEC). One characteristic that makes the described cells desirable is that they can be maintained in culture for a number of days, or passages, without changing phenotype through differentiation.
    Type: Grant
    Filed: October 1, 2014
    Date of Patent: August 20, 2019
    Assignee: The USA, as represented by the Secretary, Department of Health and Human Services
    Inventors: Manfred Boehm, Guibin Chen, Mahendra Rao, Andre Larochelle
  • Publication number: 20160222348
    Abstract: Described herein are cells, cell culture methods, and cell culture media compositions useful for producing and maintaining iPSC-derived cell lines that are of higher purity and maintain cell type integrity better than current iPSC-derived cell lines. Also disclosed are methods of using the described cells and media, such as therapeutic methods of use for the described cells. The described cells include iPSC-derived mesodermal precursor cells (MPC), which itself may differentiate into at least four different cell types. When cultured under appropriate conditions, the mesodermal precursor cells can be used to produce hematopoietic stem cells (HSC), mesenchymal stem cells (MSC), smooth muscle cells (SMC), or unlimited functional endothelial cells (UFEC). One characteristic that makes the described cells desirable is that they can be maintained in culture for a number of days, or passages, without changing phenotype through differentiation.
    Type: Application
    Filed: October 1, 2014
    Publication date: August 4, 2016
    Inventors: Manfred BOEHM, Guibin CHEN, Mahendra RAO, Andre LAROCHELLE
  • Patent number: D917571
    Type: Grant
    Filed: July 18, 2019
    Date of Patent: April 27, 2021
    Assignee: Guangzhou Unique Electronics Co., Ltd.
    Inventor: Guibin Chen
  • Patent number: D997573
    Type: Grant
    Filed: November 15, 2021
    Date of Patent: September 5, 2023
    Inventor: Guibin Chen
  • Patent number: D1014066
    Type: Grant
    Filed: March 18, 2022
    Date of Patent: February 13, 2024
    Inventor: Guibin Chen